Literature DB >> 30390066

Laser capture microdissection-targeted mass spectrometry: a method for multiplexed protein quantification within individual layers of the cerebral cortex.

Matthew L MacDonald1,2, Daley Favo3, Megan Garver3, Zhe Sun4, Dominique Arion3, Ying Ding4, Nathan Yates5, Robert A Sweet3, David A Lewis3.   

Abstract

The mammalian neocortex is organized into layers distinguished by the size, packing density, and connectivity of their constituent neurons. Many neuropsychiatric illnesses are complex trait disorders with etiologic factors converging on neuronal protein networks. Cortical pathology of neuropsychiatric diseases, such as schizophrenia, is often restricted to, or more pronounced in, certain cortical layers, suggesting that genetic vulnerabilities manifest with laminar specificity. Thus, the ability to investigate cortical layer-specific protein levels in human postmortem brain is highly desirable. Here, we developed and validated a laser capture microdissection-mass spectrometry (LCM-MS) approach to quantify over 200 proteins in cortical layers 3 and 5 of two cohorts of human subjects as well as a monkey model of postmortem interval. LCM-MS was readily implementable and reliably identified protein patterns that differed between cortical layers 3 and 5. Our findings suggest that LCM-MS facilitates the precise quantification of proteins within individual cortical layers from human postmortem brain tissue, providing a powerful tool in the study of neuropsychiatric disease.

Entities:  

Mesh:

Year:  2018        PMID: 30390066      PMCID: PMC6372704          DOI: 10.1038/s41386-018-0260-0

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  40 in total

1.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia.

Authors:  L A Glantz; D A Lewis
Journal:  Arch Gen Psychiatry       Date:  2000-01

2.  Multiple cellular antigen detection by ICP-MS.

Authors:  O Ornatsky; V I Baranov; D R Bandura; S D Tanner; J Dick
Journal:  J Immunol Methods       Date:  2005-11-21       Impact factor: 2.303

3.  Nonphosphorylated neurofilament protein and calbindin immunoreactivity in layer III pyramidal neurons of human neocortex.

Authors:  T L Hayes; D A Lewis
Journal:  Cereb Cortex       Date:  1992 Jan-Feb       Impact factor: 5.357

Review 4.  Neuronal migration in the adult brain: are we there yet?

Authors:  H Troy Ghashghaei; Cary Lai; E S Anton
Journal:  Nat Rev Neurosci       Date:  2007-02       Impact factor: 34.870

5.  Molecular markers distinguishing supragranular and infragranular layers in the human prefrontal cortex.

Authors:  Dominique Arion; Travis Unger; David A Lewis; Károly Mirnics
Journal:  Eur J Neurosci       Date:  2007-03       Impact factor: 3.386

Review 6.  Global signatures of protein and mRNA expression levels.

Authors:  Raquel de Sousa Abreu; Luiz O Penalva; Edward M Marcotte; Christine Vogel
Journal:  Mol Biosyst       Date:  2009-10-01

7.  A comparative analysis of the distribution of prosomatostatin-derived peptides in human and monkey neocortex.

Authors:  T L Hayes; J L Cameron; J D Fernstrom; D A Lewis
Journal:  J Comp Neurol       Date:  1991-01-22       Impact factor: 3.215

8.  Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts.

Authors:  C Anthony Altar; Linda W Jurata; Vin Charles; Andrew Lemire; Peng Liu; Yury Bukhman; Theresa A Young; Jeff Bullard; Hiroko Yokoe; Maree J Webster; Michael B Knable; Jeffrey A Brockman
Journal:  Biol Psychiatry       Date:  2005-07-15       Impact factor: 13.382

9.  Infragranular gene expression disturbances in the prefrontal cortex in schizophrenia: signature of altered neural development?

Authors:  Dominique Arion; Szatmár Horváth; David A Lewis; Károly Mirnics
Journal:  Neurobiol Dis       Date:  2009-12-23       Impact factor: 5.996

10.  Six degrees of separation: on the prior probability that schizophrenia susceptibility genes converge on synapses, glutamate and NMDA receptors.

Authors:  P J Harrison; V A West
Journal:  Mol Psychiatry       Date:  2006-11       Impact factor: 15.992

View more
  5 in total

Review 1.  Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease.

Authors:  Tamas Fulop; Shreyansh Tripathi; Serafim Rodrigues; Mathieu Desroches; Ton Bunt; Arnold Eiser; Francois Bernier; Pascale B Beauregard; Annelise E Barron; Abdelouahed Khalil; Adam Plotka; Katsuiku Hirokawa; Anis Larbi; Christian Bocti; Benoit Laurent; Eric H Frost; Jacek M Witkowski
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-04       Impact factor: 2.570

2.  Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer's Disease.

Authors:  Lenora Higginbotham; Eric B Dammer; Duc M Duong; Erica Modeste; Thomas J Montine; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Proteomes       Date:  2019-08-27

Review 3.  Advances in Proteomics Allow Insights Into Neuronal Proteomes.

Authors:  Erin Fingleton; Yan Li; Katherine W Roche
Journal:  Front Mol Neurosci       Date:  2021-04-15       Impact factor: 5.639

Review 4.  Targeting prefrontal cortex GABAergic microcircuits for the treatment of alcohol use disorder.

Authors:  Kenneth N Fish; Max E Joffe
Journal:  Front Synaptic Neurosci       Date:  2022-08-29

Review 5.  Investigating Post-translational Modifications in Neuropsychiatric Disease: The Next Frontier in Human Post-mortem Brain Research.

Authors:  Melanie J Grubisha; Robert A Sweet; Matthew L MacDonald
Journal:  Front Mol Neurosci       Date:  2021-07-16       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.